• 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 安徽省优秀科技期刊
  • 中国高校优秀期刊

晚期喉咽癌术后同步放化疗与术后单纯放疗疗效比较

李特, 李洪涛, 姬长友, 张民, 刘蓉蓉

李特, 李洪涛, 姬长友, 张民, 刘蓉蓉. 晚期喉咽癌术后同步放化疗与术后单纯放疗疗效比较[J]. 蚌埠医科大学学报, 2014, 39(8): 1028-1030.
引用本文: 李特, 李洪涛, 姬长友, 张民, 刘蓉蓉. 晚期喉咽癌术后同步放化疗与术后单纯放疗疗效比较[J]. 蚌埠医科大学学报, 2014, 39(8): 1028-1030.
LI Te, LI Hong-tao, JI Chang-you, ZHANG Min, LIU Rong-rong. The clinical effect of postoperative chemoradiation and radiotherapy on advanced hypopharyngeal carcinoma[J]. Journal of Bengbu Medical University, 2014, 39(8): 1028-1030.
Citation: LI Te, LI Hong-tao, JI Chang-you, ZHANG Min, LIU Rong-rong. The clinical effect of postoperative chemoradiation and radiotherapy on advanced hypopharyngeal carcinoma[J]. Journal of Bengbu Medical University, 2014, 39(8): 1028-1030.

晚期喉咽癌术后同步放化疗与术后单纯放疗疗效比较

详细信息
    作者简介:

    李特(1981-),男,硕士,住院医师.

  • 中图分类号: R739.6

The clinical effect of postoperative chemoradiation and radiotherapy on advanced hypopharyngeal carcinoma

  • 摘要: 目的:比较晚期喉咽癌术后同步放化疗与术后单纯放疗的疗效。方法:72例晚期喉咽癌患者手术后接受单纯放疗37例(放疗组),其中保留喉功能(保喉)手术者20例,非保喉手术者17例;手术后进行同步放疗与化疗35例(同步放化疗组),其中保喉手术者24例,非保喉手术者11例。比较2组生存率和生活质量,同时比较保喉者(44例)与非保喉者(28例)生存率。结果:放疗组患者3年生存率48.65%,5年生存率24.32%;同步放化疗组患者3年生存率71.43%,5年生存率48.57%,2组患者3年和5年生存率差异均有统计学意义(P<0.05);2组不良反应发生率差异均无统计学意义(P>0.05);2组患者咽瘘发生率以及吞咽、语言功能恢复情况差异均无统计学意义(P>0.05)。保喉者3年生存率40.90%,5年生存率27.27%,非保喉者3年生存率60.71%,5年生存率39.28%,2组患者3年和5年生存率差异均无统计学意义(P>0.05)。结论:晚期喉咽癌患者术后进行同步放化疗比术后单纯放疗3年及5年生存率高,且不增加不良反应,不影响患者术后生活质量;保喉手术与非保喉手术3年和5年生存率均无明显不同,可根据患者情况尽量保留喉功能。
    Abstract: Objective: To explore the clinical effects of postoperative chemoradiation and radiotherapy on advanced hypopharyngeal carcinoma.Methods: Thirty-seven patients with advanced hypopharyngeal carcinoma(including 20 cases with laryngeal function and 17 cases without laryngeal function) were treated with radiotherapy after surgery(radiotherapy group),35 patients with advanced hypopharyngeal carcinoma(including 24 cases with laryngeal function and 11 cases without laryngeal function) were treated with chemoradiation after surgery(chemoradiation group).The survival rate and life quality of two groups were compared,and the survival rate of patients with and without laryngeal function was compared.Results: The 3-year and 5-year survival rates in radiotherapy group and chemoradiation group were 48.65% & 71.43% and 24.32% & 48.57%,respectively,the difference of which was statistically significant(P<0.05).The differences of the incidence rates of toxicity and pharyngeal fistula,and the swallowing function and linguistic function recovery in two groups were not statistically significant(P>0.05).The 3-year and 5-year survival rates in patients with and without without laryngeal function were 40.90% & 60.71% and 27.27% & 39.28%,respectively,the difference of which was not statistically significant(P>0.05).Conclusions: The survival rates of 3-and 5-year of patients with advanced hypopharyngeal carcinoma treated with chemoradiation are higher than those of patients treated only with radiotherapy,the treatment does not increase the toxicity and affect the life quality of postoperative patients.The survival rates of 3-and 5-year of patients with and without laryngeal function are similar,and the laryngeal function can be preserved according to the disease.
  • [1] 唐平章.头颈肿瘤的诊治现状与展望[J].中国医学科学院学报, 2006, 28(3):311-314.
    [2]

    Kim S, Wu HG, Heo DS, et al.Advanced hypopharyngeal carcinoma treatment results according to treatment modalities[J].Head Neck, 2001, 23(9):713-717.

    [3] 房居高, 魏秀春, 李思忠, 等.喉癌喉咽癌哨位淋巴结的临床初步研究[J].中华耳鼻咽喉科杂志, 2001, 36(4):241-243.
    [4] 于锋, 董玉礼, 祖志将, 等.喉咽癌手术及综合治疗的临床资料分析[J].中华耳鼻咽喉科杂志, 2003, 38(4):295-299.
    [5]

    International Cancer Congress.Abstracts of the 18th UICC International Cancer Congress.30 June-5 July 2002.Oslo, Norway[J].Int J Cancer Suppl, 2002, 13:521-526.

    [6]

    Hughes R.NCI-CTC vs TNS:which tool is better for grading the severity of chemotherapy-induced peripheral neuropathy?[J].Nat Clin Pract Neurol, 2008, 4(2):68-69.

    [7] 李学忠, 张立强, 潘新良, 等.保留喉功能的梨状窝癌的手术治疗[J].中华耳鼻咽喉头颈外科杂志, 2005, 40(3):212-216.
    [8] 王晓雷, 徐震纲, 唐平章.T3和T4期梨状窝癌的综合治疗[J].中华耳鼻咽喉头颈外科杂志, 2006, 41(2):123-127.
    [9] 施清圆, 李文峰, 李刚, 等.晚期喉咽癌术后综合治疗的疗效及生存分析[J].临床耳鼻咽喉头颈外科杂志, 2013, 27(4):206-209.
    [10] 王晓雷, 屠规益, 徐震纲, 等.晚期喉咽癌围手术期放疗及喉功能保留[J].中国耳鼻咽喉头颈外科, 2007, 14(2):71-73.
    [11] 李晓明, 宋琦.喉癌喉咽癌的辅助与综合治疗[J].中国耳鼻咽喉头颈外科, 2009, 15(10):555-557.
    [12] 徐宜全, 齐胜.后期同步放化疗治疗局部晚期喉咽癌临床观察[J].现代肿瘤医学, 2009, 17(5):841-843.
    [13] 黄辉, 徐震纲, 唐平章, 等.梨状窝癌术前同步放化疗对手术并发症影响的临床研究[J].中华耳鼻咽喉头颈外科杂志, 2011, 46(2):114-117.
    [14] 许光普, 曾宗渊, 陈福进, 等.新辅助化疗治疗喉癌喉咽癌的近期疗效评价[J].临床肿瘤学杂志, 2002, 7(6):413-415.
    [15] 叶飞, 黄桂球, 傅敏仪.保留喉发声功能手术治疗伴声嘶的梨状窝癌[J].听力学及言语疾病杂志, 2012, 20(3):289-290.
计量
  • 文章访问数:  2831
  • HTML全文浏览量:  207
  • PDF下载量:  30
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-07-19

目录

    /

    返回文章
    返回